Научная статья
в журнале «Anaesthesia 2021»
в журнале «Anaesthesia 2021»
Recommendations for standards of monitoring during
anaesthesia and recovery 2021
anaesthesia and recovery 2021
Guideline fromthe Association of Anaesthetists
This guideline updates and replaces the 5th edition of the Standards of Monitoring published in 2015. The aim of this document is to provide guidance on the minimum standards for monitoring of any patient undergoing anaesthesia or sedation under the care of an anaesthetist. The recommendations are primarily aimed at anaesthetists practising in the UK and Ireland, but it is recognised that these guidelines may also be of use in other areas of the world. Minimum standards for monitoring patients during anaesthesia and in the recovery phase are included. There is also guidance on monitoring patients undergoing sedation and during transfer.
There are new sections specifically discussing capnography, sedation and regional anaesthesia. In addition, the indications for processed electroencephalogram and neuromuscular monitoring have been updated.
There are new sections specifically discussing capnography, sedation and regional anaesthesia. In addition, the indications for processed electroencephalogram and neuromuscular monitoring have been updated.
Дата публикации: 26 February 2021
Timing of surgery following SARS-CoV-2 infection:
an international prospective cohort study
an international prospective cohort study
Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine
the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This
international, multicentre, prospective cohort study included patients undergoing elective or emergency
surgery during October 2020.
the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This
international, multicentre, prospective cohort study included patients undergoing elective or emergency
surgery during October 2020.
Surgical patients with pre-operative SARS-CoV-2 infection were compared with
those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative
mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time
from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients
(2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2
infection was 1.5% (95%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was
increased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio
(95%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed ≥ 7 weeks after SARSCoV-
2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9–2.1)). After a
≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a
higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2–
8.7) vs. 2.4% (95%CI 1.4–3.4) vs. 1.3% (95%CI 0.6–2.0), respectively).
those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative
mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time
from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients
(2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2
infection was 1.5% (95%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was
increased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio
(95%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed ≥ 7 weeks after SARSCoV-
2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9–2.1)). After a
≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a
higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2–
8.7) vs. 2.4% (95%CI 1.4–3.4) vs. 1.3% (95%CI 0.6–2.0), respectively).
Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay.
#COVID-19; #delay; #SARS-CoV-2; #surgery; #timing
